• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢腺癌中1p36处杂合性频繁缺失,但编码p73的基因不太可能是靶点。

Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinomas but the gene encoding p73 is unlikely to be the target.

作者信息

Imyanitov E N, Birrell G W, Filippovich I, Sorokina N, Arnold J, Mould M A, Wright K, Walsh M, Mok S C, Lavin M F, Chenevix-Trench G, Khanna K K

机构信息

Group of Molecular Diagnostics, N.N. Petrov Institute of Oncology, St.-Petersburg, 189646, Russia.

出版信息

Oncogene. 1999 Aug 12;18(32):4640-2. doi: 10.1038/sj.onc.1202863.

DOI:10.1038/sj.onc.1202863
PMID:10467409
Abstract

Loss of heterozygosity (LOH) involving the distal part of the short arm of chromosome 1 occurs frequently in ovarian adenocarcinomas but the tumour suppressor gene(s) targeted by this event is unknown. We have used five microsatellite markers in a panel of 56 ovarian adenocarcinomas to determine which part of 1p34 - 36 is the focus of this LOH. LOH was considerably more common at 1p36 (43%) than at 1p34 - 35 (18%), and 11 tumours showed LOH at 1p36 but not at 1p34 - 35. These data strongly suggest the presence of a tumour suppressor gene inactivated in ovarian adenocarcinoma at 1p36. The p53 homologue, p73, has recently been isolated and mapped to 1p36 and therefore is a candidate for this tumour suppressor gene. However, RT - PCR and Western analyses revealed strong expression of p73 in ovarian adenocarcinoma cell lines but very low or undetectable levels in normal ovarian surface epithelial cells. Immunohistochemical analysis of primary ovarian tumours showed that only 3/22 (14%) contained p73 expressing cells. There was no association between 1p36 LOH and p73 expression in ovarian tumours, nor between p73 and p53 expression. These findings strongly suggest that p73 is not the target of 1p36 LOH in ovarian adenocarcinomas but indicate the presence of an, as yet unidentified, tumour suppressor gene in this region that plays an important role in ovarian tumorigenesis.

摘要

1号染色体短臂远端杂合性缺失(LOH)在卵巢腺癌中频繁发生,但该事件所靶向的肿瘤抑制基因尚不清楚。我们在一组56例卵巢腺癌中使用了5个微卫星标记,以确定1p34 - 36的哪一部分是这种LOH的焦点。1p36处的LOH(43%)比1p34 - 35处(18%)更为常见,并且有11个肿瘤在1p36处显示LOH,但在1p34 - 35处未显示。这些数据强烈提示在1p36处存在一个在卵巢腺癌中失活的肿瘤抑制基因。p53同源物p73最近已被分离并定位于1p36,因此是这个肿瘤抑制基因的一个候选者。然而,逆转录聚合酶链反应(RT - PCR)和蛋白质免疫印迹分析显示,p73在卵巢腺癌细胞系中强烈表达,但在正常卵巢表面上皮细胞中水平极低或无法检测到。对原发性卵巢肿瘤的免疫组织化学分析表明,仅3/22(14%)含有表达p73的细胞。在卵巢肿瘤中,1p36 LOH与p73表达之间没有关联,p73与p53表达之间也没有关联。这些发现强烈提示p73不是卵巢腺癌中1p36 LOH的靶点,但表明在该区域存在一个尚未确定的肿瘤抑制基因,它在卵巢肿瘤发生中起重要作用。

相似文献

1
Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinomas but the gene encoding p73 is unlikely to be the target.卵巢腺癌中1p36处杂合性频繁缺失,但编码p73的基因不太可能是靶点。
Oncogene. 1999 Aug 12;18(32):4640-2. doi: 10.1038/sj.onc.1202863.
2
Frequent allelic losses on the short arm of chromosome 1 and decreased expression of the p73 gene at 1p36.3 in squamous cell carcinoma of the oral cavity.口腔鳞状细胞癌中1号染色体短臂上频繁的等位基因缺失以及1p36.3处p73基因表达降低。
Int J Oncol. 2002 Feb;20(2):355-60.
3
Frequent loss of heterozygosity at 1p36.3 and p73 abnormality in parathyroid adenomas.甲状旁腺腺瘤中1p36.3频繁杂合性缺失及p73异常
Mod Pathol. 2001 Apr;14(4):273-8. doi: 10.1038/modpathol.3880302.
4
Clinical value of alterations in p73 gene, related to p53 at 1p36, in human hepatocellular carcinoma.1p36上与p53相关的p73基因改变在人类肝细胞癌中的临床价值
Int J Oncol. 2004 Feb;24(2):441-6.
5
p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent.位于1号染色体1p36.3的p73在晚期神经母细胞瘤中缺失,但它的突变并不常见。
Oncogene. 1999 Jan 28;18(4):1061-6. doi: 10.1038/sj.onc.1202390.
6
Absence of mutation of the p73 gene in astrocytic neoplasms.星形细胞瘤中p73基因无突变。
Int J Oncol. 2001 Sep;19(3):609-12. doi: 10.3892/ijo.19.3.609.
7
p73, a gene related to p53, is not mutated in esophageal carcinomas.与p53相关的基因p73在食管癌中未发生突变。
Int J Cancer. 1998 Nov 9;78(4):437-40. doi: 10.1002/(sici)1097-0215(19981109)78:4<437::aid-ijc8>3.0.co;2-v.
8
Alterations of p73 preferentially occur in gastric adenocarcinomas with foveolar epithelial phenotype.
Int J Cancer. 1999 Oct 8;83(2):192-6. doi: 10.1002/(sici)1097-0215(19991008)83:2<192::aid-ijc8>3.0.co;2-e.
9
Differential expression of p73 splice variants and protein in benign and malignant ovarian tumours.p73剪接变体和蛋白在卵巢良恶性肿瘤中的差异表达
Int J Cancer. 2000 Oct 1;88(1):66-70.
10
Genetic alternations of p73 are infrequent but may occur in early stage hepatocellular carcinoma.p73的基因改变并不常见,但可能在早期肝细胞癌中出现。
Anticancer Res. 2000 May-Jun;20(3A):1487-92.

引用本文的文献

1
Expression of CHD5 may serve as an independent biomarker of prognosis in colorectal cancer via immunohistochemical staining.通过免疫组织化学染色,CHD5的表达可能作为结直肠癌预后的独立生物标志物。
Int J Clin Exp Pathol. 2018 May 1;11(5):2792-2798. eCollection 2018.
2
SPOC1-mediated antiviral host cell response is antagonized early in human adenovirus type 5 infection.在人5型腺病毒感染早期,SPOC1介导的抗病毒宿主细胞反应受到拮抗。
PLoS Pathog. 2013;9(11):e1003775. doi: 10.1371/journal.ppat.1003775. Epub 2013 Nov 21.
3
A naturally occurring p73 mutation in a p73-p53 double-mutant lung cancer cell line encodes p73 alpha protein with a dominant-negative function.
一种p73-p53双突变肺癌细胞系中天然存在的p73突变编码具有显性负性功能的p73α蛋白。
Cancer Sci. 2003 Aug;94(8):718-24. doi: 10.1111/j.1349-7006.2003.tb01508.x.
4
Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas.卵巢腺癌中1p36.1处Id3基因表达降低。
Br J Cancer. 2001 Feb 2;84(3):352-9. doi: 10.1054/bjoc.2000.1620.